DGPPN 2018 Programm

POSTERPRÄSENTATIONEN 203 MITTWOCH DONNERSTAG FREITAG SAMSTAG 002 Differences in inhibition between female and male patients with alcohol use disorders – preliminary results Raphaela Martina Tschümperlin, Bern (Schweiz) Hallie Batschelet, Franz Moggi, Thomas König, Susanne Rösner, Anne Keller, Alexander Wopfner, Leila Soravia, Maria Stein 003 Risk factors of addictive behavior formation in young people in Belarusian population Sergey Igumnov, Minsk (Weißrussland) K. Zbarousky, P. Lapanau 004 Emotional abuse experience is asso- ciated with emotion regulation deficits in substance abuse patients Elisa Stein, Berlin Christina Maria Koch, Peter Neu 005 New BDNF mimetic with antidepres- sant-like activity induce prominent atten- uation of opiate withdrawal indices and long-standing analgesia: an experimental study Mark Konstantinopolsky, Moskau (Russland) Larisa Kolik, Tatiana Gudasheva 006 Substance abuse in older adults Karen Reimers, Minneapolis (USA) 007 Neurophysiological correlates of context-dependent inhibition in alcohol use disorder Maria Stein, Bern (Schweiz) Werner Fey, Leonie Steiner, Andrea Federspiel, Thomas König, Franz Moggi P-25 (e) Postersitzung 13:30– 15:00 Uhr | Saal Helsinki 1 /2 TOPIC 3: Psychotische Störungen, F2 Psychotic disorders Vorsitz: Berend Malchow, Jena 001 N-methyl-D-aspartate receptor an- tibody encephalitis presenting as acute psychosis: a case report Eva Lamadé, Bad Soden am Taunus Volker Jost, Eva Maria Craemer, Uta Meyding-Lamadé 002 A neural signature of abnormal cortical development in patients with schizophrenia who have persistent audi- tory verbal hallucinations Robert Christian Wolf, Heidelberg 003 Clinical symptomatology in correla- tion with social functionating among first time diagnosed schizophrenia spec- trum patients in a rural region of Latvia Karina Bezina, Daugavpils (Lettland) Liene Berze, Konstantins Pavlovs, Elmars Rancans, Sarmite Kikuste, Inna Sapele, Natalja Kurakina 004 Multisensory visual-tactile inte- gration compensates for unisensory processing deficits in schizophrenia James Moran, Berlin Julian Keil, Felix Bermpohl, Daniel Senkowski 005 Oculomotor dysfunction and neurocognitive deficits in schizophrenia continuum Tatsiana Skuhareuskaya, Minsk (Weißrussland) Ilya Obyedkov 006 Differences in (an-)hedonia between subjects with schizophrenia and healthy controls Janina Richter, Tübingen Lea Hölz, Stefan Klingberg 007 Violent offending in schizophrenia- spectrum disorders preceding and fol- lowing diagnosis Henning Hachtel, Basel (Schweiz) 008 Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: func- tioning and resource use Katalin Pungor, Neuss María Paz Garcia-Portilla, Pierre Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Ozguven, Sung-Wan Kim, Paul Bergmans, Irina Usankova, Pierre Cherubin 009 Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany Christoph Potempa, Burscheid Reinhard P. T. Rychlik Englischsprachige Veranstaltung